A pharmaceutical composition for inhibiting the recurrence, progression or metastasis of liver cancer is provided. The pharmaceutical composition includes a compound of formula (I) and a pharmaceutically acceptable carrier.本案提出一種用於抑制肝癌復發、惡化或轉移之醫藥組成物,該醫藥組成物係包含通式(I)化合物及一醫藥上可接受之載體。